Navigation Links
The Society for Immunotherapy of Cancer Recognizes Cancer Immunotherapy Month™
Date:5/31/2019

Throughout the month of June, SITC will recognize “Cancer Immunotherapy Month™” by highlighting 30 ways the organization is shaping the future of cancer immunotherapy through the society’s social media platforms. “Cancer Immunotherapy Month™” was started by the Cancer Research Institute in 2013, with the goal of raising awareness for cancer immunotherapy. SITC is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.

“Cancer Immunotherapy Month™ is an ideal opportunity to recognize the important progress immunotherapy has made in improving outcomes for subsets of patients across many different types of cancer. The advances in treatment are truly remarkable but there is much work to be done,” said SITC President Mario Sznol, MD. “By highlighting our efforts, and the groundbreaking work of others in this very important month, we hope to continue raising awareness of the benefit that cancer immunotherapy can provide. We also hope to raise awareness of the importance of continued research to realize its full potential.”

SITC also provides a variety of informative, free resources to educate patients, clinicians and researchers about cancer immunotherapy. These resources take the form of live events and online tools, including:

  • For patients: Understanding Cancer Immunotherapy (Fifth Edition): Developed specifically for newly diagnosed and restaged cancer patients and their caregivers, this online activity, outlines the basics about how the immune system works to fight cancer, the types of cancer immunotherapy treatment and clinical trials as a treatment option for cancer patients.
  • For clinicians: Basic Principles of Cancer Immunotherapy: SITC's Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with U.S. Food and Drug Administration (FDA)-approved cancer immunotherapy treatments. Written by world-recognized thought leaders in the field of cancer immunotherapy, this text provides thorough coverage of the toxicity and management of adverse events experienced during treatment with immune checkpoint inhibitors.
  • For researchers: Primer on Tumor Immunology and Cancer Immunotherapy™: Shared with an audience of researchers, these presentations from the society’s 33rd Annual Meeting (SITC 2018) are designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer.
  • For clinicians, students and patient advocates: Advances in Cancer Immunotherapy™ (ACI) is comprised of CME-, CNE-, CPE- and MOC-accredited in-person meetings, webinars and interactive online courses presented by leading local authorities in tumor immunology and cancer immunotherapy. Free for healthcare professionals, students and patient advocates, these programs teach the latest in immunotherapy issues, treatment options and clinical implementation strategies.
  • For scientists: SITC will host will host two timely, back-to-back workshops Sept. 4–6, 2019, in Houston, Texas, that will address critical challenges, facilitate innovative collaborations, and develop strategies to ensure continued momentum in the field of cancer immunotherapy. Registration to attend the workshops, which will focus on cancer immune responsiveness and adoptive cellular therapies, now open.

“For more than three decades, SITC has served as a major catalyst in spurring collaborations among researchers and clinicians that trigger breakthroughs in cancer immunotherapy,” said James P. Allison, PhD, 2018 Nobel Laureate. “As a proud SITC member of 18 years, I look forward to continuing support of the society’s mission of improving cancer patient outcomes by advancing the science, development and application of cancer immunotherapy.”

For more information, please visit SITC’s website at http://www.sitcancer.org.

About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at http://www.sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.

# # #

Read the full story at https://www.prweb.com/releases/the_society_for_immunotherapy_of_cancer_recognizes_cancer_immunotherapy_month/prweb16337872.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. The National Children’s Cancer Society Provides Life-Changing Mentor Relationship
2. Cardiology Society Gets to the “Heart” of Hypertrophic Cardiomyopathy
3. Dr. Mark S. Milner to Present on Cryopreserved Amniotic Membrane at 2019 American Society of Cataract and Refractive Surgery (ASCRS)
4. Society for Immunotherapy of Cancer Announces 2019 Recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship
5. Athletic Trainers’ Society of New Jersey Award Winners Recognized at the ATSNJ 33rd Annual Conference and Business Meeting
6. Neil Riordan, PA, PhD Presents at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th
7. Neil Riordan, PA, PhD Presents at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th
8. Announcing Society for Tennis Medicine and Science 2019 Tennis Medicine Conference
9. The Pennsylvania Athletic Trainers’ Society Young Professionals Committee Hosts Southeast Region CEU Event in Conjunction with Temple University and Go4Ellis
10. Mediaplanet Partners with the American Society of Transplantation, National Kidney Fund and more to Advocate for Organ Donation
11. Mindray Showcases New Gem Series for Ultrasound Platforms at Annual Radiological Society of North America Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2019)... ... 2019 , ... HR Maximizer Inc ( https://hrmaximizer.com ) announced ... Houston Healthcare HR Association (HHHRA - https://hhhra.org ). In addition to ... University, PageUp, CRC, Alliance Work Partners and Kognito. , Houston Healthcare HR Association, ...
(Date:6/16/2019)... ... 14, 2019 , ... GTB Technologies, the global leader ... the coveted “2019 Best DLP Solution Provider” Award from Acquisition International and will ... additions to its Data Security Portfolio (DSP) during the Gartner Security and Risk ...
(Date:6/16/2019)... ... June 16, 2019 , ... Ted Danson on ... scientific research for the advancement of medical marijuana-based pharmaceuticals in an upcoming episode, ... for more information. , With two investigational new drug applications already accepted by ...
(Date:6/14/2019)... ... June 14, 2019 , ... This past Saturday, volunteers from ... support staff hosted the Parma Heights Day of Giving, where members of underserved communities ... through local nonprofits that partnered with the Smiles for Everyone Foundation. Some ...
(Date:6/13/2019)... ... June 13, 2019 , ... Women’s Excellence in Obstetrics and Gynecology specializes in pelvic pain treatment ... be difficult to diagnosis. Women’s Excellence handles routine and complicated pelvic pain conditions including:, ... Endometriosis , Heavy periods , Adhesions (scar tissue) , ...
Breaking Medicine News(10 mins):
(Date:6/24/2019)... ... 24, 2019 , ... Houston Methodist has pledged $2 million ... Lodge. The hospital system’s support gift was announced today during a traditional ... the building’s frame and celebrate the significant milestone. , During the event, ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... MedMark Treatment Centers Columbus East, its first opioid treatment program (OTP) in ... The clinic, located at 1805 E. Main Street, Columbus, is now accepting ...
(Date:6/20/2019)... ... , ... LuckyVitamin, an e-commerce specialty retailer and manufacturer of ... Employers of 2019. LuckyVitamin’s Founder and Chief Wellness Spreader, Sam Wolf, along with ... the Ballroom at the Ben on June 13, 2019. , This highly sought-after ...
Breaking Medicine Technology: